Green and red organic light-emitting diodes employing excimer emitters

ABSTRACT

Organic light emitting devices (OLEDs) are described, the OLEDs comprising an anode; a cathode; and an organic region, disposed between the anode and the cathode, comprising a first complex and a second complex; wherein when a voltage is applied across the anode and cathode at room temperature, the OLED emits a luminescent radiation that comprises one or more luminescent radiation components resulting from the formation of at least one exciplex; wherein the exciplex is formed by at least one of the following aggregate types: 1) at least one aggregate within the first complex, and at least one aggregate within the second complex; 2) at least one aggregate between the first and the second complex; and 3) both 1 and 2.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims priority to U.S. Provisional Application No. 62/909,341, filed Oct. 2, 2019, which is incorporated by reference herein in its entirety.

BACKGROUND OF THE INVENTION

During the last decade, organic light emitting diodes (OLEDs) have undergone great development in the display industry, such as improved performance in both color and definition. In 2009, LG solved the large size OLED display and commercialized a 15-inch OLED TV set which was based on a fine metal mask (FMM) and low temperature poly silicon (LTPS) thin film transistor (TFT). In the emitting portions of the device forming the full color display, the blue stack and red/green (R/G) stack consist of an RGB sub-pixel. Since a highly stable phosphorescent blue emitter is very difficult to achieve, the fluorescent blue stack has since been replaced in the commercial TV. For the R/G layer, highly stable and efficient materials were applied. Although the R/G pixel is commercial now, searching for much more efficient and stable materials is of utmost interest in the OLED research.

There is need in the art for green and/or red emitters having high stability and efficiency. The present invention satisfies this unmet need.

SUMMARY

In one aspect, the present disclosure relates to an organic light emitting device (OLED) comprising:

-   -   an anode;     -   a cathode; and     -   an organic region, disposed between the anode and the cathode,         comprising a first complex and a second complex;     -   wherein when a voltage is applied across the anode and cathode         at room temperature, the OLED emits a luminescent radiation that         comprises one or more luminescent radiation components resulting         from the formation of at least one exciplex;     -   wherein the exciplex is formed by at least one of the following         aggregate types:     -   1) at least one aggregate within the first complex, and at least         one aggregate within the second complex;     -   2) at least one aggregate between the first and the second         complex; and     -   3) both 1 and 2.

According to another aspect, the OLED is incorporated into a consumer product.

BRIEF DESCRIPTION OF THE DRAWINGS

The following detailed description of preferred embodiments of the invention will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities of the embodiments shown in the drawings.

FIG. 1 is a schematic diagram of a hybrid tandem white OLED (WOLED) structure.

FIG. 2 depicts an OLED.

FIG. 3 depicts the photoluminescence (PL) emission of thin film Pd3O8-P.

FIG. 4 depicts the PL emission of different kinds of excimer emitters.

FIG. 5 depicts the electroluminescence spectra of the devices in Example 2.

FIG. 6 depicts the electroluminescence spectra of the devices in Example 3.

FIG. 7 is a plot of current density-voltage characteristics for these devices in Example 4.

FIG. 8 is a plot of electroluminescence (EL) spectra of the devices in Example 4.

FIG. 9 is a plot of EQE vs current density for these devices in Example 4.

FIG. 10 is a plot of relative luminance versus operation time at current densities of 20 mA cm⁻² for the devices of Example 4.

DETAILED DESCRIPTION Definitions

It is to be understood that the figures and descriptions of the present invention have been simplified to illustrate elements that are relevant for a clear understanding of the present invention, while eliminating, for the purpose of clarity, many other elements found in the art related to phosphorescent organic light emitting devices and the like. Those of ordinary skill in the art may recognize that other elements and/or steps are desirable and/or required in implementing the present invention. However, because such elements and steps are well known in the art, and because they do not facilitate a better understanding of the present invention, a discussion of such elements and steps is not provided herein. The disclosure herein is directed to all such variations and modifications to such elements and methods known to those skilled in the art.

Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods, materials and components similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods, and materials are described.

As used herein, each of the following terms has the meaning associated with it in this section.

The articles “a” and “an” are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, “an element” means one element or more than one element.

“About” as used herein when referring to a measurable value such as an amount, a temporal duration, and the like, is meant to encompass variations of ±20%, ±10%, ±5%, ±1%, or ±0.1% from the specified value, as such variations are appropriate.

Throughout this disclosure, various aspects of the invention can be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 2.7, 3, 4, 5, 5.3, 6 and any whole and partial increments therebetween. This applies regardless of the breadth of the range.

Disclosed are the components to be used to prepare the compositions of the disclosure as well as the compositions themselves to be used within the methods disclosed herein. These and other materials are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these materials are disclosed that while specific reference of each various individual and collective combinations and permutation of these compounds cannot be explicitly disclosed, each is specifically contemplated and described herein. For example, if a particular compound is disclosed and discussed and a number of modifications that can be made to a number of molecules including the compounds are discussed, specifically contemplated is each and every combination and permutation of the compound and the modifications that are possible unless specifically indicated to the contrary. Thus, if a class of molecules A, B, and C are disclosed as well as a class of molecules D, E, and F and an example of a combination molecule, A-D is disclosed, then even if each is not individually recited each is individually and collectively contemplated meaning combinations, A-E, A-F, B-D, B-E, B-F, C-D, C-E, and C-F are considered disclosed. Likewise, any subset or combination of these is also disclosed. Thus, for example, the sub-group of A-E, B-F, and C-E would be considered disclosed. This concept applies to all aspects of this application including, but not limited to, steps in methods of making and using the compositions of the invention. Thus, if there are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific embodiment or combination of embodiments of the methods of the invention.

As referred to herein, a linking atom or a linking group can connect two groups such as, for example, an N and C group. The linking atom can optionally, if valency permits, have other chemical moieties attached. For example, in one aspect, an oxygen would not have any other chemical groups attached as the valency is satisfied once it is bonded to two groups (e.g., N and/or C groups). In another aspect, when carbon is the linking atom, two additional chemical moieties can be attached to the carbon. Suitable chemical moieties includes, but are not limited to, hydrogen, hydroxyl, alkyl, alkoxy, ═O, halogen, nitro, amine, amide, thiol, aryl, heteroaryl, cycloalkyl, and heterocyclyl.

The term “cyclic structure” or the like terms used herein refer to any cyclic chemical structure which includes, but is not limited to, aryl, heteroaryl, cycloalkyl, cycloalkenyl, and heterocyclyl.

As used herein, the term “substituted” is contemplated to include all permissible substituents of organic compounds. In a broad aspect, the permissible substituents include acyclic and cyclic, branched and unbranched, carbocyclic and heterocyclic, and aromatic and nonaromatic substituents of organic compounds. Illustrative substituents include, for example, those described below. The permissible substituents can be one or more and the same or different for appropriate organic compounds. For purposes of this disclosure, the heteroatoms, such as nitrogen, can have hydrogen substituents and/or any permissible substituents of organic compounds described herein which satisfy the valences of the heteroatoms. This disclosure is not intended to be limited in any manner by the permissible substituents of organic compounds. Also, the terms “substitution” or “substituted with” include the implicit proviso that such substitution is in accordance with permitted valence of the substituted atom and the substituent, and that the substitution results in a stable compound, e.g., a compound that does not spontaneously undergo transformation such as by rearrangement, cyclization, elimination, etc. It is also contemplated that, in certain aspects, unless expressly indicated to the contrary, individual substituents can be further optionally substituted (i.e., further substituted or unsubstituted).

The term “alkyl” as used herein is a branched or unbranched saturated hydrocarbon group of 1 to 24 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl group can be cyclic or acyclic. The alkyl group can be branched or unbranched. The alkyl group can also be substituted or unsubstituted. For example, the alkyl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol, as described herein. A “lower alkyl” group is an alkyl group containing from one to six (e.g., from one to four) carbon atoms.

Throughout the specification “alkyl” is generally used to refer to both unsubstituted alkyl groups and substituted alkyl groups; however, substituted alkyl groups are also specifically referred to herein by identifying the specific substituent(s) on the alkyl group. For example, the term “halogenated alkyl” or “haloalkyl” specifically refers to an alkyl group that is substituted with one or more halide, e.g., fluorine, chlorine, bromine, or iodine. The term “alkoxyalkyl” specifically refers to an alkyl group that is substituted with one or more alkoxy groups, as described below. The term “alkylamino” specifically refers to an alkyl group that is substituted with one or more amino groups, as described below, and the like. When “alkyl” is used in one instance and a specific term such as “alkylalcohol” is used in another, it is not meant to imply that the term “alkyl” does not also refer to specific terms such as “alkylalcohol” and the like.

This practice is also used for other groups described herein. That is, while a term such as “cycloalkyl” refers to both unsubstituted and substituted cycloalkyl moieties, the substituted moieties can, in addition, be specifically identified herein; for example, a particular substituted cycloalkyl can be referred to as, e.g., an “alkylcycloalkyl.” Similarly, a substituted alkoxy can be specifically referred to as, e.g., a “halogenated alkoxy,” a particular substituted alkenyl can be, e.g., an “alkenylalcohol,” and the like. Again, the practice of using a general term, such as “cycloalkyl,” and a specific term, such as “alkylcycloalkyl,” is not meant to imply that the general term does not also include the specific term.

The term “cycloalkyl” as used herein is a non-aromatic carbon-based ring composed of at least three carbon atoms. Examples of cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, norbornyl, and the like. The term “heterocycloalkyl” is a type of cycloalkyl group as defined above, and is included within the meaning of the term “cycloalkyl,” where at least one of the carbon atoms of the ring is replaced with a heteroatom such as, but not limited to, nitrogen, oxygen, sulfur, or phosphorus. The cycloalkyl group and heterocycloalkyl group can be substituted or unsubstituted. The cycloalkyl group and heterocycloalkyl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, or thiol as described herein.

The term “polyalkylene group” as used herein is a group having two or more CH₂ groups linked to one another. The polyalkylene group can be represented by the formula —(CH2)_(n)—, where “a” is an integer of from 2 to 500.

The terms “alkoxy” and “alkoxyl” as used herein to refer to an alkyl or cycloalkyl group bonded through an ether linkage; that is, an “alkoxy” group can be defined as —OA¹ where A¹ is alkyl or cycloalkyl as defined above. “Alkoxy” also includes polymers of alkoxy groups as just described; that is, an alkoxy can be a polyether such as —OA¹- OA² or —OA¹-(OA²)_(a)-OA³, where “a” is an integer of from 1 to 200 and A¹, A², and A³ are alkyl and/or cycloalkyl groups.

The term “alkenyl” as used herein is a hydrocarbon group of from 2 to 24 carbon atoms with a structural formula containing at least one carbon-carbon double bond. Asymmetric structures such as (A¹A²)C═C(A³A⁴) are intended to include both the E and Z isomers. This can be presumed in structural formulae herein wherein an asymmetric alkene is present, or it can be explicitly indicated by the bond symbol C═C. The alkenyl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol, as described herein.

The term “cycloalkenyl” as used herein is a non-aromatic carbon-based ring composed of at least three carbon atoms and containing at least one carbon-carbon double bond, i.e., C═C. Examples of cycloalkenyl groups include, but are not limited to, cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclopentadienyl, cyclohexenyl, cyclohexadienyl, norbornenyl, and the like. The term “heterocycloalkenyl” is a type of cycloalkenyl group as defined above, and is included within the meaning of the term “cycloalkenyl,” where at least one of the carbon atoms of the ring is replaced with a heteroatom such as, but not limited to, nitrogen, oxygen, sulfur, or phosphorus. The cycloalkenyl group and heterocycloalkenyl group can be substituted or unsubstituted. The cycloalkenyl group and heterocycloalkenyl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol as described herein.

The term “alkynyl” as used herein is a hydrocarbon group of 2 to 24 carbon atoms with a structural formula containing at least one carbon-carbon triple bond. The alkynyl group can be unsubstituted or substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol, as described herein.

The term “cycloalkynyl” as used herein is a non-aromatic carbon-based ring composed of at least seven carbon atoms and containing at least one carbon-carbon triple bound. Examples of cycloalkynyl groups include, but are not limited to, cycloheptynyl, cyclooctynyl, cyclononynyl, and the like. The term “heterocycloalkynyl” is a type of cycloalkenyl group as defined above, and is included within the meaning of the term “cycloalkynyl,” where at least one of the carbon atoms of the ring is replaced with a heteroatom such as, but not limited to, nitrogen, oxygen, sulfur, or phosphorus. The cycloalkynyl group and heterocycloalkynyl group can be substituted or unsubstituted. The cycloalkynyl group and heterocycloalkynyl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol as described herein.

The term “aryl” as used herein is a group that contains any carbon-based aromatic group including, but not limited to, benzene, naphthalene, phenyl, biphenyl, phenoxybenzene, and the like. The term “aryl” also includes “heteroaryl,” which is defined as a group that contains an aromatic group that has at least one heteroatom incorporated within the ring of the aromatic group. Examples of heteroatoms include, but are not limited to, nitrogen, oxygen, sulfur, and phosphorus. Likewise, the term “non-heteroaryl,” which is also included in the term “aryl,” defines a group that contains an aromatic group that does not contain a heteroatom. The aryl group can be substituted or unsubstituted. The aryl group can be substituted with one or more groups including, but not limited to, alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, aldehyde, amino, carboxylic acid, ester, ether, halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol as described herein. The term “biaryl” is a specific type of aryl group and is included in the definition of “aryl.” Biaryl refers to two aryl groups that are bound together via a fused ring structure, as in naphthalene, or are attached via one or more carbon-carbon bonds, as in biphenyl.

The term “aldehyde” as used herein is represented by the formula —C(O)H. Throughout this specification “C(O)” is a short hand notation for a carbonyl group, i.e., C═O.

The terms “amine” or “amino” as used herein are represented by the formula —NA¹A², where A¹ and A² can be, independently, hydrogen or alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “alkylamino” as used herein is represented by the formula —NH(-alkyl) where alkyl is a described herein. Representative examples include, but are not limited to, methylamino group, ethylamino group, propylamino group, isopropylamino group, butylamino group, isobutylamino group, (sec-butyl)amino group, (tert-butyl)amino group, pentylamino group, isopentylamino group, (tert-pentyl)amino group, hexylamino group, and the like.

The term “dialkylamino” as used herein is represented by the formula —N(-alkyl)₂ where alkyl is a described herein. Representative examples include, but are not limited to, dimethylamino group, diethylamino group, dipropylamino group, diisopropylamino group, dibutylamino group, diisobutylamino group, di(sec-butyl)amino group, di(tert-butyl)amino group, dipentylamino group, diisopentylamino group, di(tert-pentyl)amino group, dihexylamino group, N-ethyl-N-methylamino group, N-methyl-N-propylamino group, N-ethyl-N-propylamino group and the like.

The term “carboxylic acid” as used herein is represented by the formula —C(O)OH.

The term “ester” as used herein is represented by the formula —OC(O)A¹ or —C(O)OA¹, where A¹ can be alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein. The term “polyester” as used herein is represented by the formula -(A¹O(O)C-A²-C(O)O), or -(A¹O(O)C-A²-OC(O))_(a)—, where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group described herein and “a” is an integer from 1 to 500. “Polyester” is as the term used to describe a group that is produced by the reaction between a compound having at least two carboxylic acid groups with a compound having at least two hydroxyl groups.

The term “ether” as used herein is represented by the formula A¹OA², where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group described herein. The term “polyether” as used herein is represented by the formula -(A¹O-A²O)_(a)—, where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group described herein and “a” is an integer of from 1 to 500. Examples of polyether groups include polyethylene oxide, polypropylene oxide, and polybutylene oxide.

The term “halide” as used herein refers to the halogens fluorine, chlorine, bromine, and iodine.

The term “heterocyclyl,” as used herein refers to single and multi-cyclic non-aromatic ring systems and “heteroaryl” as used herein refers to single and multi-cyclic aromatic ring systems: in which at least one of the ring members is other than carbon. The term “heterocyclyl” includes azetidine, dioxane, furan, imidazole, isothiazole, isoxazole, morpholine, oxazole, oxazole, including, 1,2,3-oxadiazole, 1,2,5-oxadiazole and 1,3,4-oxadiazole, piperazine, piperidine, pyrazine, pyrazole, pyridazine, pyridine, pyrimidine, pyrrole, pyrrolidine, tetrahydrofuran, tetrahydropyran, tetrazine, including 1,2,4,5-tetrazine, tetrazole, including 1,2,3,4-tetrazole and 1,2,4,5-tetrazole, thiadiazole, including, 1,2,3-thiadiazole, 1,2,5-thiadiazole, and 1,3,4-thiadiazole, thiazole, thiophene, triazine, including 1,3,5-triazine and 1,2,4-triazine, triazole, including, 1,2,3-triazole, 1,3,4-triazole, and the like.

The term “hydroxyl” as used herein is represented by the formula —OH.

The term “ketone” as used herein is represented by the formula A¹C(O)A², where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “azide” as used herein is represented by the formula —N₃.

The term “nitro” as used herein is represented by the formula —NO₂.

The term “nitrile” as used herein is represented by the formula —CN.

The term “ureido” as used herein refers to a urea group of the formula —NHC(O)NH₂ or —NHC(O)NH—.

The term “phosphoramide” as used herein refers to a group of the formula —P(O)(NA¹A²)₂, where A¹ and A² can be, independently, hydrogen or an alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “carbamoyl” as used herein refers to an amide group of the formula —CONA¹A², where A¹ and A² can be, independently, hydrogen or an alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “sulfamoyl” as used herein refers to a group of the formula —S(O)₂NA¹A², where A¹ and A² can be, independently, hydrogen or an alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “silyl” as used herein is represented by the formula —SiA¹A²A³, where A¹, A², and A³ can be, independently, hydrogen or an alkyl, cycloalkyl, alkoxy, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “sulfo-oxo” as used herein is represented by the formulas —S(O)A¹, —S(O)₂A¹, —OS(O)₂A¹, or —OS(O)₂OA¹, where A¹ is hydrogen or an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein. Throughout this specification “S(O)” is a short hand notation for S═O. The term “sulfonyl” is used herein to refer to the sulfo-oxo group represented by the formula —S(O)₂A¹, where A¹ is hydrogen or an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein. The term “sulfone” as used herein is represented by the formula A¹S(O)₂A², where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein. The term “sulfoxide” as used herein is represented by the formula A¹S(O)A², where A¹ and A² can be, independently, an alkyl, cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as described herein.

The term “thiol” as used herein is represented by the formula —SH.

The term “polymeric” includes polyalkylene, polyether, polyester, and other groups with repeating units, such as, but not limited to —(CH₂O)_(n)—CH₃, —(CH₂CH₂O)_(n)—CH₃, —[CH₂CH(CH₃)]_(n)—CH₃, —[CH₂CH(COOCH₃)]_(n)—CH₃, —[CH₂CH(COOCH₂CH₃)]_(n)—CH₃, and —[CH₂CH(COO^(t)Bu)]_(n)—CH₃, where n is an integer (e.g., n>1 or n>2).

“R,” “R¹,” “R²,” “R³,” “R^(n),” where n is an integer, as used herein can, independently, include hydrogen or one or more of the groups listed above. For example, if R¹ is a straight chain alkyl group, one of the hydrogen atoms of the alkyl group can optionally be substituted with a hydroxyl group, an alkoxy group, an alkyl group, a halide, and the like. Depending upon the groups that are selected, a first group can be incorporated within a second group or, alternatively, the first group can be pendant (i.e., attached) to the second group. For example, with the phrase “an alkyl group comprising an amino group,” the amino group can be incorporated within the backbone of the alkyl group. Alternatively, the amino group can be attached to the backbone of the alkyl group. The nature of the group(s) that is (are) selected will determine if the first group is embedded or attached to the second group.

As described herein, compounds of the disclosure may contain “optionally substituted” moieties. In general, the term “substituted,” whether preceded by the term “optionally” or not, means that one or more hydrogens of the designated moiety are replaced with a suitable substituent. Unless otherwise indicated, an “optionally substituted” group may have a suitable substituent at each substitutable position of the group, and when more than one position in any given structure may be substituted with more than one substituent selected from a specified group, the substituent may be either the same or different at every position. Combinations of substituents envisioned by this disclosure are preferably those that result in the formation of stable or chemically feasible compounds. It is also contemplated that, in certain aspects, unless expressly indicated to the contrary, individual substituents can be further optionally substituted (i.e., further substituted or unsubstituted).

In some aspects, a structure of a compound can be represented by a formula:

which is understood to be equivalent to a formula:

wherein n is typically an integer. That is, R^(n) is understood to represent five independent substituents, R^(n(a)), R^(n(b)), R^(n(c)), R^(n(d)), R^(n(e)). By “independent substituents,” it is meant that each R substituent can be independently defined. For example, if in one instance R^(n(a)) is halogen, then R^(n(b)) is not necessarily halogen in that instance.

Several references to R, R¹, R², R³, R⁴, R⁵, R⁶, etc. are made in chemical structures and moieties disclosed and described herein. Any description of R, R¹, R², R₃, R₄, R⁵, R⁶, etc. in the specification is applicable to any structure or moiety reciting R, R¹, R², R₃, R₄, R⁵, R⁶, etc. respectively.

Compositions of the Invention

In one aspect, the present invention relates to a composition comprising a first complex and a second complex, wherein the first complex and the second complex each have a structure independently selected from General Formula I and General Formula II:

-   -   wherein, in General Formula I and General Formula II:     -   M represents Pt(II), Pd(II), Ir(I), Rh(I), Au(III);     -   Y^(1a), Y^(1b), Y^(1c), Y^(1f), Y^(1g), Y^(1h), Y^(2a), Y^(2b),         Y^(2c), Y^(2f), Y^(2g), Y^(2h) each independently represents C         or N;     -   Y^(1d), Y^(1e), Y^(2d), Y^(2e) each is independently absent or         present, and if present, Y^(1d), Y^(1e), Y^(2d), Y^(2e) each         independently represents C or N;     -   X and X¹ each is independently present or absent, and, if         present, each of X and X¹ independently represents C, N, Si, O,         S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each         independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B,         BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O,         AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or         BiR⁷;     -   R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ each is independently absent         or present as a single substituent or multiple substituents,         valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵,         R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium,         halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile,         sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or         unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl,         heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino,         dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy,         haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino,         alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino,         sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl,         polymeric; or any conjugate or combination thereof;     -   L¹, L³, L⁴,and L⁶ each independently represents a 5- to         10-membered aryl, heteroaryl, fused aryl, or fused heteroaryl;     -   L² and L⁵ each is independently present or absent, and, if         present, L² and L⁵ each independently represents a 5- to         10-membered aryl, heteroaryl, fused aryl, or fused heteroaryl;     -   V¹, V², V³, V⁴ each is independently present, absent, or a         covalent bond, and if present, each of V¹, V², V³, V⁴         independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al,         or Bi, or if valency permits, each independently represents CR⁷,         SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O,         SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O,         SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi=O, or BiR⁷;     -   each n is independently an integer, valency permitting;     -   wherein the first complex and the second complex have different         structures.

In one embodiment, at least one of V³, V⁴, or X¹ is present in General Formula I or General Formula II.

In one embodiment, M in one of the first complex and the second complex is Pt(II); and M in the other of the first complex and the second complex is Pd(II).

In one embodiment, the first complex and the second complex each have a structure of General Formula I.

In one embodiment, at least one of the first complex and the second complex is a complex of General Formula III, General Formula IV, General Formula V, or General Formula VI

-   -   wherein, in General Formulas III-VI:     -   M represents Pt(II), Pd(II), Ir(I), Rh(I), or Au(III);     -   each Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(2a), Y^(2b), Y^(2c),         Y^(2d), Y^(2e), Y^(2f), Y^(3a), Y^(3b), Z¹, Z², Z³, and Z⁴         independently represents C or N;     -   X and X¹ each is independently present or absent, and, if         present, each of X and X¹ independently represents C, N, Si, O,         S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each         independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B,         BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C—O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O,         AsR⁷, R⁷As—O, S—O, SO₂, Se—O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or         BiR⁷;     -   A, B, C, and D each independently represents C, N, O, or S;     -   R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ each is independently absent         or present as a single substituent or multiple substituents,         valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵,         R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium,         halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile,         sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or         unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl,         heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino,         dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy,         haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino,         alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino,         sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl,         polymeric; or any conjugate or combination thereof;     -   L⁴, L⁵, and L⁶ each independently represents a 5- to 10-membered         aryl, heteroaryl, fused aryl, or fused heteroaryl;     -   V¹ and V² each is independently present, absent, or a covalent         bond, and if present, each of V¹ and V² independently represents         C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency         permits, each independently represents CR⁷, SiR⁷, GeR⁷, NR⁷,         P═O, As═O, B, BR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸,         R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷, AlR⁷R⁸,         R⁷Bi═O, or BiR⁷; and     -   each n is independently an integer, valency permitting.

In one embodiment, at least one of V¹, V², or X¹ is present in General Formulas III-VI.

In one embodiment, one of the first complex and the second complex has a structure of General Formula III, and the other of the first complex and the second complex has a structure of General Formula IV.

In one embodiment, at least one of the first complex and the second complex is a complex of General Formula VII, General Formula VIII, General Formula IX, General Formula X, General Formula XI, General Formula XII, General Formula XIII, General Formula XIV, General Formula XV, General Formula XVI, General Formula XVII, General Formula XVIII, General Formula XIX, General Formula XX, General Formula XXI, General Formula XXII, General Formula XXIII, or General Formula XXIV:

-   -   wherein, in General Formulas VII-XXIV:     -   Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h),         Y^(1i), Y^(1j), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f),         Y^(2g), Y^(2h), Y^(2i), Y^(2j) each independently represents C         or N;     -   X is independently present or absent, and, if present, X         independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al,         or Bi, or if valency permits, X independently represents CR⁷,         SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O,         SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O,         SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷;     -   A, B, C, D, A¹, B¹, C¹, and D¹ each independently represents C,         N, O, S;     -   R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent         or present as a single substituent or multiple substituents,         valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵,         R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium,         halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile,         sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or         unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl,         heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino,         dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy,         haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino,         alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino,         sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl,         polymeric; or any conjugate or combination thereof; and     -   each n is independently an integer, valency permitting.

In one embodiment, at least one of the first complex and the second complex has a structure of General Formula VIII.

In one embodiment, at least one of the first complex and the second complex is a complex of General Formula XXV, General Formula XXVI, General Formula XXVII, General Formula XXVIII, General Formula XXIX, General Formula XXX, General Formula XXXI, or General Formula XXXII:

-   -   wherein, in General Formulas XXV-XXXII:     -   Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h),         Y^(1i), Y^(1j), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f),         Y^(2g), Y^(2h), Y^(2i), Y^(2j) each independently represents C         or N;     -   X is independently present or absent, and, if present, X         independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al,         or Bi, or if valency permits, X independently represents CR⁷,         SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O,         SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O,         SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷;     -   A, B, C, D each independently represents C, N, O, S;     -   R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent         or present as a single substituent or multiple substituents,         valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵,         R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium,         halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile,         sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or         unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl,         heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino,         dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy,         haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino,         alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino,         sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl,         polymeric; or any conjugate or combination thereof; and     -   each n is independently an integer, valency permitting.

In one embodiment, at least one of the first complex and the second complex is a complex of General Formula XXXIII, General Formula XXXIV, or General Formula XXXV:

-   -   wherein, in General Formulas XXXIII-XXXV:     -   Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h),         Y^(1i), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f), Y^(2g),         Y^(2h), Y^(2i), each independently represents C or N;     -   X is independently present or absent, and, if present, X         independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al,         or Bi, or if valency permits, each X independently represents         CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O,         SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O,         SeO₂, BR⁷R⁸, AlR⁷, AlR⁷R⁸, R⁷Bi═O, or BiR⁷;     -   R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent         or present as a single substituent or multiple substituents,         valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵,         R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium,         halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile,         sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or         unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl,         heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino,         dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy,         haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino,         alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino,         sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl,         polymeric; or any conjugate or combination thereof; and     -   each n is independently an integer, valency permitting.

In one embodiment, the dotted lines in any of General Formulas III-XXXV indicate that the dotted bonds and/or atoms may be present or may not be present.

In one embodiment, in at least one of the first complex and the second complex, each instance of R¹-R⁵ in any of General Formulas I-XXXV comprises hydrogen.

In one embodiment, in at least one of the first complex and the second complex, at least one R² in any of General Formulas I-XXXV is a C₁-C₆ linear alkyl group. In one embodiment, at least one R² in any of General Formulas I-XXXV is a C₃-C₆ branched alkyl group.

In one embodiment, in at least one of the first complex and the second complex, at least one R² in any of General Formulas I-XXXV is selected from the group consisting of:

In one embodiment, in at least one of the first complex and the second complex, at least one R² in any of General Formulas I-XXXV is an optionally substituted aryl group. In one embodiment, at least one R² in any of General Formulas I-XXXV is an optionally substituted C₆-C₂₄ aryl group. In one embodiment, at least one R² in any of General Formulas I-XXXV is a C₆ aryl group substituted with one or more C₁-C₆ linear alkyl groups. In one embodiment, at least one R² in any of General Formulas I-XXXV is a C₆ aryl group substituted with one or more C₃-C₆ branched alkyl groups.

In one embodiment, in at least one of the first complex and the second complex, at least one R² in any of General Formulas I-XXXV is selected from the group consisting of:

In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a C₁-C₆ linear alkyl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a C₃-C₆ branched alkyl group.

In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is selected from the group consisting of:

In one embodiment, in at least one of the first complex and the second complex, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an optionally substituted aryl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an optionally substituted C₆-C₂₄ aryl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an unsubstituted C₆-C₂₄ aryl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a C₆-C₂₄ aryl group substituted with one or more C₁-C₆ linear alkyl groups. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a C₆-C₂₄ aryl group substituted with one or more C₃-C₆ branched alkyl groups.

In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is selected from the group consisting of:

In one embodiment, in at least one of the first complex and the second complex, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an optionally substituted heteroaryl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an optionally substituted heteroaryl group comprising at least one heteroatom selected from the group consisting of N, S, and O. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is an unsubstituted heteroaryl group. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a heteroaryl group substituted with one or more C₁-C₆ linear alkyl groups. In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is a heteroaryl group substituted with one or more C₃-C₆ branched alkyl groups.

In one embodiment, at least one of R¹, R², R³, R⁴, R⁵, or R⁶ in any of General Formulas I-XXXV is selected from the group consisting of:

-   -   wherein R and R⁹ each independently represents hydrogen,         deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile,         isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino;         substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl,         heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino,         monoalkylamino, dialkylamino, monoarylamino, diarylamino,         alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl,         acylamino, alkoxycarbonylamino, aryloxycarbonylamino,         sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido,         phosphoramide, silyl, polymeric; or any conjugate or combination         thereof.

In one embodiment, L³ in General Formula I or II is a benzene ring. In one embodiment, L⁴ in General Formula I or II is a benzene ring. In one embodiment, L¹ in General Formula I or II is a pyridine ring. In one embodiment, L¹ in General Formula I or II is an imidazole ring. In one embodiment, L¹ in General Formula I or II is an imidazoline ring. In one embodiment, L¹ in General Formula I or II is a benzimidazole ring. In one embodiment, L⁶ in General Formula I or II is a pyridine ring. In one embodiment, X in General Formula I or II is O. In one embodiment, L² and L⁵ in General Formula I or II is absent. In one embodiment, L² and L⁵ in General Formula I or II are present. In one embodiment, L² in General Formula I or II is present and L⁵ in General Formula I or II is absent. In one embodiment, L² in General Formula I or II is a benzene ring. In one embodiment, each of V¹, V², V³, and V⁴ in General Formula I or II is absent. In one embodiment, X¹ in General Formula II is absent.

In one embodiment, X in any of General Formulas I-XXXV comprises O.

In one embodiment, the compound is a compound of General Formula VIII wherein Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(2a), Y^(2b), Y^(2c), and Y^(2d) are absent; Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(2e), Y^(2f), Y^(2g), Y^(2h), and Y^(2i) are each C; X is O; and R¹, R², R³, R⁴, R⁵, and R⁶ are each hydrogen, valency permitting.

In one embodiment, the compound is a compound of General Formula XVII wherein Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(2a), Y^(2b), Y^(2c), and Y^(2d) are absent; Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(2e), Y^(2f), Y^(2g), Y^(2h), and Y^(2i) are each C; X is O; and R¹, R², R³, R⁴, R⁵, and R⁶ are each hydrogen, valency permitting.

In one embodiment, the compound is a compound of General Formula XVIII wherein Y^(1a), Y^(1b), Y^(1c), and Y^(1d) are absent; Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(2e), Y^(2f), Y^(2g), Y^(2h), and Y^(2j) are C; A¹, B¹, and D¹ are C; C¹ is N; X is O; and R¹, R², R³, R⁴, R⁵, and R⁶ are each hydrogen, valency permitting.

In one embodiment, at least one of the first complex and the second complex is selected from the group consisting of:

In one embodiment, each of the first complex and the second complex is independently selected from the group consisting of:

In one embodiment, the ratio of the first complex to the second complex in the composition can be any ratio as would be understood by a person of ordinary skill in the art. In one embodiment, the ratio of the first complex to the second complex is any ratio between about 99:1 and about 1:99. In one embodiment, the ratio of the first complex to the second complex is about 1:1. In one embodiment, the ratio of the first complex to the second complex is about 10:90. In one embodiment, the ratio of the first complex to the second complex is about 90:10. In one embodiment, the ratio of the first complex to the second complex is about 4:96. In one embodiment, the ratio of the first complex to the second complex is about 96:4.

In one embodiment, at least one of the first complex and the second complex is an emitter. In one embodiment, at least one of the first complex and the second complex is an excimer emitter. In one embodiment, at least one of the first complex and the second complex is a red excimer emitter. In one embodiment, at least one of the first complex and the second complex is a green excimer emitter. In one embodiment, the composition emits in both the red and green regions of the electromagnetic spectrum.

Devices of the Invention

Also disclosed herein are devices comprising the composition disclosed herein.

In one aspect, the device is an electro-optical device. Electro-optical devices include, but are not limited to, photo-absorbing devices such as solar- and photo-sensitive devices, organic light emitting diodes (OLEDs), photo-emitting devices, or devices capable of both photo-absorption and emission and as markers for bio-applications. For example, the device can be an OLED.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), which are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

In one aspect, the present disclosure relates to an organic light emitting device (OLED), the OLED comprising an anode;

-   -   a cathode; and     -   an organic region, disposed between the anode and the cathode,         comprising a first complex and a second complex;     -   wherein when a voltage is applied across the anode and cathode         at room temperature, the OLED emits a luminescent radiation that         comprises one or more luminescent radiation components resulting         from the formation of at least one exciplex;     -   wherein the exciplex is formed by at least one of the following         aggregate types:     -   1) at least one aggregate within the first complex, and at least         one aggregate within the second complex;     -   2) at least one aggregate between the first and the second         complex; and     -   3) both 1 and 2.

In one embodiment, the first complex is a green emitter and the second complex is a red emitter. In one embodiment, the luminescent radiation component comprises red light, green light, or a mixture of red light and green light. In one embodiment, the organic region comprises a mixed layer comprising the first complex and the second complex. In one embodiment, the organic region comprises at least one sublayer comprising the first complex and at least one sublayer comprising the second complex.

In one embodiment, the first complex and the second complex each has a structure of any of General Formulas I-XXXV. In one embodiment, the OLED device comprises an excimer emitter of any of General Formulas I-XXXV. In one embodiment, the OLED device comprises multiple excimer emitters of any of General Formulas I-XXXV. In one embodiment, the OLED device comprises one or more red excimer emitters of any of General Formulas I-XXXV. In one embodiment, the OLED device comprises one or more green excimer emitters of any of General Formulas I-XXXV. In one embodiment, the OLED device comprises one or more excimer emitters of any of General Formulas I-XXXV that emit in both the red and green regions of the electromagnetic spectrum.

In one aspect, the present invention includes an organic layer that includes a first complex and a second complex. In one embodiment, one of the first complex and second complex is a red emitter and the other of the first complex and the second complex is a green emitter. In one embodiment, the organic layer includes one red emitter and one green emitter. In one embodiment, the red emitter is a compound of any one of General Formulas I-XXXV. In one embodiment, the green emitter is a compound of any one of General Formulas I-XXXV.

The ratio of the red emitter to the green emitter can be any ratio, as would be understood by a person of ordinary skill in the art. In one embodiment, the ratio of the red emitter to the green emitter is any ratio between about 99:1 and about 1:99. In one embodiment, the ratio of the red emitter to the green emitter is about 1:1. In one embodiment, the ratio of the red emitter to the green emitter is about 4:96. In one embodiment, the ratio of the red emitter to the green emitter is about 96:4. In one embodiment, the organic layer includes a 1:1 ratio of Pt3O3 to Pd3O3. In one embodiment, the organic layer includes a 4:96 ratio of Pt3O3 to Pd3O3. In one embodiment, the ratio of one or more red emitters to one or more green emitters can be tuned to adjust and improve performance of the device.

One application for phosphorescent emissive molecules is a full color display. FIG. 1 shows a common structure of the device which forms the full color of the display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Color may be measured using CIE coordinates, which are well known to the art. Such devices are disclosed herein which comprise one or more of the compounds or compositions disclosed herein. In one embodiment, the display comprises a red pixel comprising a compound of any of General Formulas I-XXXV. In one embodiment, the display comprises a green pixel comprising a compound of any of General Formulas I-XXXV. In one embodiment, the display comprises a red pixel comprising a compound of any of General Formulas I-XXXV and a green pixel comprising a compound of any of General Formulas I-XXXV. In one embodiment, the display comprises pixel that emits in both the red and green regions of the electromagnetic spectrum, the pixel comprising a compound of any of General Formulas I-XXXV.

OLEDs can be produced by methods known to those skilled in the art. In general, the OLED is produced by successive vapor deposition of the individual layers onto a suitable substrate. Suitable substrates include, for example, glass, inorganic materials such as ITO or IZO or polymer films. For the vapor deposition, customary techniques may be used, such as thermal evaporation, chemical vapor deposition (CVD), physical vapor deposition (PVD), and others.

In an alternative process, the organic layers may be coated from solutions or dispersions in suitable solvents, in which case coating techniques known to those skilled in the art are employed. Suitable coating techniques are, for example, spin-coating, the casting method, the Langmuir-Blodgett (“LB”) method, the inkjet printing method, dip-coating, letterpress printing, screen printing, doctor blade printing, slit-coating, roller printing, reverse roller printing, offset lithography printing, flexographic printing, web printing, spray coating, coating by a brush or pad printing, and the like. Among the processes mentioned, in addition to the aforementioned vapor deposition, preference is given to spin-coating, the inkjet printing method and the casting method since they are particularly simple and inexpensive to perform. In the case that layers of the OLED are obtained by the spin-coating method, the casting method or the inkjet printing method, the coating can be obtained using a solution prepared by dissolving the composition in a concentration of 0.0001 to 90% by weight in a suitable organic solvent such as benzene, toluene, xylene, tetrahydrofuran, methyltetrahydrofuran, N,N-dimethylformamide, acetone, acetonitrile, anisole, dichloromethane, dimethyl sulfoxide, water, and mixtures thereof.

Compositions described herein can be used in a light emitting device such as an OLED. FIG. 2 depicts a cross-sectional view of an OLED 100. OLED 100 includes substrate 102, anode 104, hole-transporting material(s) (HTL) 106, light processing material 108, electron-transporting material(s) (ETL) 110, and a metal cathode layer 112. Anode 104 is typically a transparent material, such as indium tin oxide. Light processing material 108 may be an emissive material (EML) including an emitter and a host. In one embodiment, Light processing material 108 is an emissive material (EML) including a composition described herein.

In various aspects, any of the one or more layers depicted in FIG. 2 may include indium tin oxide (ITO), poly(3,4-ethylenedioxythiophene) (PEDOT), polystyrene sulfonate (PSS), N,N′-di-1-naphthyl-N,N-diphenyl-1,1′-biphenyl-4,4′diamine (NPD), 1,1-bis((di-4-tolylamino)phenyl)cyclohexane (TAPC), 2,6-Bis(N-carbazolyl)pyridine (mCpy), 2,8-bis(diphenylphosphoryl)dibenzothiophene (PO15), LiF, Al, or a combination thereof.

Light processing material 108 may include one or more compounds of the present disclosure optionally together with a host material. In one embodiment, the light processing material comprises one or more compounds of the present disclosure as an emissive material. The host material can be any suitable host material known in the art. In one embodiment, the emission color of an OLED is determined by the emission energy (optical energy gap) of the light processing material 108, which can be tuned by tuning the electronic structure of the emitting compounds, the host material, or both. Both the hole-transporting material in the HTL layer 106 and the electron-transporting material(s) in the ETL layer 110 may include any suitable hole-transporter known in the art.

Compounds described herein may exhibit phosphorescence. Phosphorescent OLEDs (i.e., OLEDs with phosphorescent emitters) typically have higher device efficiencies than other OLEDs, such as fluorescent OLEDs. Light emitting devices based on electrophosphorescent emitters are described in more detail in WO2000/070655 to Baldo et al., which is incorporated herein by this reference for its teaching of OLEDs, and in particular phosphorescent OLEDs.

As contemplated herein, an OLED of the present invention may include an anode, a cathode, and an organic layer/region disposed between the anode and the cathode. The organic layer may include a host and a phosphorescent dopant. The organic layer can include a compound of the invention and its variations as described herein.

In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.

In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises an RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiment, the OLED is a large size display having at least a 15 inch diagonal. In some embodiments, the OLED is a lighting panel.

In one embodiment, the consumer product is selected from the group consisting of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, and a sign.

In some embodiments of the emissive region, the emissive region further comprises a host, wherein the host comprises at least one selected from the group consisting of metal complex, triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, aza-triphenylene, aza-carbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.

The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used maybe a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, CC—CnH2n+1, Ar1, Ar1-Ar2, and CnH2n-Ar1, or the host has no substitutions. In the preceding substituents n can range from 1 to 10; and Ar1 and Ar2 can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example, a Zn containing inorganic material e.g. ZnS.

Suitable hosts may include, but are not limited to, mCP (1,3-bis(carbazol-9-yl)benzene), mCPy (2,6-bis(N-carbazolyl)pyridine), TCP (1,3,5-tris(carbazol-9-yl)benzene), TCTA (4,4′,4″-tris(carbazol-9-yl)triphenylamine), TPBi (1,3,5-tris(1-phenyl-1-H-benzimidazol-2-yl)benzene), mCBP (3,3-di(9H-carbazol-9-yl)biphenyl), pCBP (4,4′-bis(carbazol-9-yl)biphenyl), CDBP (4,4′-bis(9-carbazolyl)-2,2′-dimethylbiphenyl), DMFL-CBP (4,4′-bis(carbazol-9-yl)-9,9-dimethylfluorene), FL-4CBP (4,4′-bis(carbazol-9-yl)-9,9-bis(9-phenyl-9H-carbazole)fluorene), FL-2CBP (9,9-bis(4-carbazol-9-yl)phenyl)fluorene, also abbreviated as CPF), DPFL-CBP (4,4′-bis(carbazol-9-yl)-9,9-ditolylfluorene), FL-2CBP (9,9-bis(9-phenyl-9H-carbazole)fluorene), Spiro-CBP (2,2′,7,7′-tetrakis(carbazol-9-yl)-9,9′-spirobifluorene), ADN (9,10-di(naphth-2-yl)anthracene), TBADN (3-tert-butyl-9,10-di(naphth-2-yl)anthracene), DPVBi (4,4′-bis(2,2-diphenylethen-1-yl)-4,4′-dimethylphenyl), p-DMDPVBi (4,4′-bis(2,2-diphenylethen-1-yl)-4,4′-dimethylphenyl), TDAF (tert(9,9-diarylfluorene)), BSBF (2-(9,9′-spirobifluoren-2-yl)-9,9′-spirobifluorene), TSBF (2,7-bis(9,9′-spirobifluoren-2-yl)-9,9′-spirobifluorene), BDAF (bis(9,9-diarylfluorene)), p-TDPVBi (4,4′-bis(2,2-diphenylethen-1-yl)-4,4′-di-(tert-butyl)phenyl), TPB3 (1,3,5-tri(pyren-1-yl)benzene, PBD (2-(4-biphenylyl)-5-(4-tert-butylphenyl)-1,3,4-oxadiazole), BCP (2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline), BP-OXD-Bpy (6,6′-bis[5-(biphenyl-4-yl)-1,3,4-oxadiazo-2-yl]-2,2′-bipyridyl), NTAZ (4-(naphth-1-yl)-3,5-diphenyl-4H-1,2,4-triazole), Bpy-OXD (1,3-bis[2-(2,2′-bipyrid-6-yl)-1,3,4oxadiazo-5-yl]benzene), BPhen (4,7-diphenyl-1,10-phenanthroline), TAZ (3-(4-biphenylyl)-4-phenyl-5-tert-butylphenyl-1,2,4-triazole), PADN (2-phenyl-9,10-di(naphth-2-yl)anthracene), Bpy-FOXD (2,7-bis[2-(2,2′-bipyrid-6-yl)-1,3,4-oxadiazol-5-yl]-9,9-dimethylfluorene), OXD-7 (1,3-bis[2-(4-tert-butylphenyl)-1,3,4-oxadiazol-5-yl]benzene), HNBphen (2-(naphth-2-yl)-4,7-diphenyl-1,10-phenanthroline), NBphen (2,9-bis(naphth-2-yl)-4,7-diphenyl-1,10-phenanthroline), 3TPYMB (tris(2,4,6-trimethyl-3-(pyrid-3-yl)phenyl)borane), 2-NPIP (1-methyl-2-(4-(naphth-2-yl)phenyl)-1H-imidazo[4,5-f]-[1,10]phenanthroline), Liq (8-hydroxyquinolinolatolithium), and Alq (bis(2-methyl-8-quinolinolate)-4-(phenylphenolato)aluminum), and also of mixtures of the aforesaid substances.

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.

Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047, and US2012146012.

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO_(x); a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

The light emitting layer of the organic EL device of the present invention preferably contains the composition described herein. In one embodiment, the light emitting layer comprises a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.

One or more additional emitter dopants may be used in conjunction with the compound of the present disclosure. Examples of the additional emitter dopants are not particularly limited, and any compounds may be used as long as the compounds are typically used as emitter materials. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.

In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.

EXPERIMENTAL EXAMPLES

The invention is further described in detail by reference to the following experimental examples. These examples are provided for purposes of illustration only and are not intended to be limiting unless otherwise specified. Thus, the invention should in no way be construed as being limited to the following examples, but rather, should be construed to encompass any and all variations which become evident as a result of the teaching provided herein.

Without further description, it is believed that one of ordinary skill in the art can, using the preceding description and the following illustrative examples, make and utilize the compounds and devices of the present invention and practice the claimed methods. The following working examples therefore, specifically point out the preferred embodiments of the present invention, and are not to be construed as limiting in any way the remainder of the disclosure.

In one aspect, the present invention relates to highly stable and efficient excimer emitting materials. In the current technology, red and green pixels are co-deposited in thin film or deposited in stack with two monomer emitting materials. In concentrated solution or thin film, a new excited species (excimer, or exciplex if between dissimilar molecules) containing one excited molecule (M*) and a ground state (M) is formed in equilibrium with the separated species. The excimer has a broad structureless phosphorescence at longer wavelengths than that of the isolated molecular excited state.

Example 1: Pd3O8-P Excimer Emitter

A very efficient excimer emitter, Pd3O8-P, has been developed (FIG. 3). In the neat thin film, the emitter gives a very good performance with an emission peak at 586 nm, a photoluminescence quantum yield (PLQY) of 86%, and an external quantum efficiency (EQE) of 33%. When the stability of the device was tested, the half lifetime (LT₅₀) was found to reach 800000 h at 5 mA/cm². This great performance demonstrates that red excimer emitter Pd3O8-P is useful as a red pixel in the large size display.

Additionally, a new R/G layer was designed for a large size display. The photoluminescence (PL) of an exemplary inventive layer is shown in FIG. 4. Both of the pixels were emitted by excimer material, which is hypothesized to be more efficient and stable than currently existing commercial materials. In the emitting layer, two or more kinds of excimer emitters could be co-deposited to achieve the red and green colors. The ratio of the two or more kinds of emitters can be tuned to adjust and improve performance of the device.

Example 2: Co-Deposited Device Comprising Pd3O3 and Pt3O3

Materials: TrisPCz (9,9′,9″-triphenyl-9H,9′H,9″H-3,3′:6′3″-tercarbazole), BPyTP (2,7-di(2,2′-bipyridin-5-yl)triphenylene), HATCN (1,4,5,8,9,11-hexaazatriphenylene-hexacarbonitrile), NPD (N,N′-diphenyl-N,N′-bis(1-naphthyl)-1,1′-biphenyl-4,4″-diamine), BAlq (bis(2-methyl-8-quinolinolato)(biphenyl-4-olato)aluminum), mCBT (9,9′-(2,8-dibenzothiophenediyl)bis-9H-carbazole), Liq (8-hydroxyquinolinolatolithium), BCN34:

A device was fabricated comprising the following structure: ITO/HATCN (10 nm)/NPD (40 nm)/EBL/50% Pt3O3:50% Pd3O3 (15 nm)/HBL/BPyTP (40 nm)/Liq (2 nm)/Al.

The EBL and HBL were varied as follows:

-   Device 1: TrisPCz (10 nm)/EML/BAlq (10 nm) -   Device 2: TrisPCz (10 nm)/EML/mCBT (8 nm) -   Device 3: BCN34 (10 nm)/EML/BAlq (10 nm).     -   Device 4: BCN34 (10 nm)/EML/mCBT (8 nm).

The electroluminescent spectra of the devices are shown in FIG. 5.

Example 3: Co-Deposited Device Comprising Pd3O3 and Pt3O3

A device was fabricated comprising the following structure: ITO/HATCN (10 nm)/NPD (40 nm)/EBL/4% Pt3O3:96% Pd3O3 (15 nm)/HBL/BPyTP (40 nm)/Liq (2 nm)/Al.

The EBL and HBL were varied as follows:

-   Device 1: TrisPCz (10 nm)/EML/BAlq (10 nm) -   Device 2: TrisPCz (10 nm)/EML/mCBT (8 nm) -   Device 3: BCN34 (10 nm)/EML/BAlq (10 nm) -   Device 4: BCN34 (10 nm)/EML/mCBT (8 nm).

The electroluminescent spectra of the devices are shown in FIG. 6.

Example 4: Co-Deposited Device Comprising Pt3O3 and Pd3O8-Py5

Devices were fabricated having the following structure: ITO (100 nm))/HATCN (10 nm)/NPD (70 nm)/TrisPCz (10 nm)/x % Pt3O3:Pd3O8-Py5 (10 nm)/BAlq (10 nm)/BPyTP (50 nm)/Liq (2 nm)/Al, where x=3, 10, 50 and 100. A plot of current Current density-voltage characteristics for these devices is shown in FIG. 7. The electroluminescence (EL) spectra of the devices is shown in FIG. 8. Plots of EQE vs current density for these devices are shown in FIG. 9. Plots of relative luminance versus operation time at current densities of 20 mA cm⁻² for these devices is shown in FIG. 10.

The structures of the compounds are presented below.

As shown in Example 3 and Example 4, the mix of two phosphorescent excimers could either produce two emission peaks originated from their pure excimer emissions (in Example 3) or shift the emission peaks based on the formation of new phosphorescent excimers (Example 4). The observed phenomena can be applied to all of the excimers based on the general formulae disclosed herein.

The disclosures of each and every patent, patent application, and publication cited herein are hereby incorporated herein by reference in their entirety. While this invention has been disclosed with reference to specific embodiments, it is apparent that other embodiments and variations of this invention may be devised by others skilled in the art without departing from the true spirit and scope of the invention. The appended claims are intended to be construed to include all such embodiments and equivalent variations. 

We claim:
 1. An organic light emitting device (OLED) comprising: an anode; a cathode; and an organic region, disposed between the anode and the cathode, comprising a first complex and a second complex; wherein when a voltage is applied across the anode and cathode at room temperature, the OLED emits a luminescent radiation that comprises one or more luminescent radiation components resulting from the formation of at least one exciplex; wherein the exciplex is formed by at least one of the following aggregate types: 1) at least one aggregate within the first complex, and at least one aggregate within the second complex; 2) at least one aggregate between the first and the second complex; and 3) both 1 and
 2. 2. The OLED of claim 1, wherein the first complex is a green emitter and the second complex is a red emitter.
 3. The OLED of claim 1, wherein the luminescent radiation component comprises red light, green light, or a mixture of red light and green light.
 4. The OLED of claim 1, wherein the organic region comprises a mixed layer comprising the first complex and the second complex.
 5. The OLED of claim 1, wherein the organic region comprises at least one sublayer comprising the first complex and at least one sublayer comprising the second complex.
 6. The OLED of claim 1, wherein the first complex and the second complex each have a structure independently selected from General Formula I and General Formula II:

wherein: M represents Pt(II), Pd(II), Ir(I), Rh(I), Au(III); Y^(1a), Y^(1b), Y^(1c), Y^(1f), Y^(1g), Y^(1h), Y^(2a), Y^(2b), Y^(2c), Y^(2f), Y^(2g), Y^(2h) each independently represents C or N; Y^(1d), Y^(1e), Y^(2d), Y^(2e) each is independently absent or present, and if present, Y^(1d), Y^(1e), Y^(2d), Y^(2e) each independently represents C or N; X and X¹ each is independently present or absent, and each of X and X¹, if present, independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ each is independently absent or present as a single substituent or multiple substituents, valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof; L¹, L³, L⁴, and L⁶ each independently represents a 5- to 10-membered aryl, heteroaryl, fused aryl, or fused heteroaryl; L² and L⁵ each is independently present or absent and, if present, L² and L⁵ each independently represents a 5- to 10-membered aryl, heteroaryl, fused aryl, or fused heteroaryl; V², V³, V⁴ each is independently present, absent, or a covalent bond, and, if present, each of V¹, V², V³, V⁴ independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; each n is independently an integer, valency permitting; and wherein the first complex and the second complex have different structures.
 7. The OLED of claim 1, wherein at least one of the first complex and the second complex is a complex of General Formula III, General Formula IV, General Formula V, or General Formula VI:

wherein: M represents Pt(II), Pd(II), Ir(I), Rh(I), or Au(III); each Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f), Y^(3a), Y^(3b), Z¹, Z², Z³, and Z⁴ independently represents C or N; X and X¹ each is independently present or absent, and, if present, each of X and X¹ independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C—O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P—O, AsR⁷, R⁷As—O, S—O, SO₂, Se—O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; A, B, C, and D each independently represents C, N, O, or S; R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ each is independently absent or present as a single substituent or multiple substituents, valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof; L⁴, L⁵, and L⁶ each independently represents a 5- to 10-membered aryl, heteroaryl, fused aryl, or fused heteroaryl; V¹ and V² each is independently present, absent, or a covalent bond, and if present, each of V¹ and V² independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; and each n is independently an integer, valency permitting.
 8. The OLED of claim 1, wherein at least one of the first complex and the second complex is a complex of General Formula VII, General Formula VIII, General Formula IX, General Formula X, General Formula XI, General Formula XII, General Formula XIII, General Formula XIV, General Formula XV, General Formula XVI, General Formula XVII, General Formula XVIII, General Formula XIX, General Formula XX, General Formula XXI, General Formula XXII, General Formula XXIII, or General Formula XXIV;

wherein: each Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(1j), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f), Y^(2g), Y^(2h), Y^(2i), and Y^(2j) each independently represents C or N; X is independently present or absent, and, if present, X independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, X independently represents CR⁷, CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; A, B, C, D, A¹, B¹, C¹, and D¹ each independently represents C, N, O, or S; R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent or present as a single substituent or multiple substituents, valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof; and each n is independently an integer, valency permitting.
 9. The OLED of claim 1, wherein at least one of the first complex and the second complex is a complex of General Formula XXV, General Formula XXVI, General Formula XXVII, General Formula XXVIII, General Formula XXIX, General Formula XXX, General Formula XXXI, or General Formula XXXII;

wherein: each Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(1j), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f), Y^(2g), Y^(2h), Y^(2i), and Y^(2j) independently represents C or N; X is independently present or absent, and, if present, X independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, X independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; A, B, C, and D each independently represents C, N, O, or S; R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent or present as a single substituent or multiple substituents, valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof; and each n is independently an integer, valency permitting.
 10. The OLED of claim 1, wherein at least one of the first complex and the second complex is a complex of General Formula XXXIII, General Formula XXXIV, or General Formula XXXV;

wherein: each Y^(1a), Y^(1b), Y^(1c), Y^(1d), Y^(1e), Y^(1f), Y^(1g), Y^(1h), Y^(1i), Y^(2a), Y^(2b), Y^(2c), Y^(2d), Y^(2e), Y^(2f), Y^(2g), Y^(2h), and Y^(2i) independently represents C or N; X is independently present or absent, and, if present, X independently represents C, N, Si, O, S, Ge, P, As, Se, B, Al, or Bi, or if valency permits, each X independently represents CR⁷, SiR⁷, GeR⁷, NR⁷, P═O, As═O, B, BR⁷, AlR⁷, Bi═O, CR⁷R⁸, C═O, SiR⁷R⁸, GeR⁷R⁸, PR⁷, PR⁷R⁸, R⁷P═O, AsR⁷, R⁷As═O, S═O, SO₂, Se═O, SeO₂, BR⁷R⁸, AlR⁷, AlR⁷R⁸, R⁷Bi═O, or BiR⁷; R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ is each independently absent or present as a single substituent or multiple substituents, valency permitting, and, if present, each of R¹, R², R³, R⁴, R⁵, R⁶, R⁷, and R⁸ independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof; and each n is independently an integer, valency permitting.
 11. The OLED of claim 1, wherein, in at least one of the first complex and the second complex, each instance of R¹-R⁵ in General Formula I or General Formula II is hydrogen.
 12. The OLED of claim 6, wherein, in at least one of the first complex and the second complex, at least one of R¹, R², R³, R⁴, R⁵, and R⁶ in General Formula I or General Formula II is selected from the group consisting of:

wherein R and R⁹ each independently represents hydrogen, deuterium, halogen, hydroxyl, thiol, nitro, cyano, nitrile, isonitrile, sulfinyl, mercapto, sulfo, carboxyl, hydrazino; substituted or unsubstituted: aryl, cycloalkyl, cycloalkenyl, heterocyclyl, heteroaryl, alkyl, alkenyl, alkynyl, amino, monoalkylamino, dialkylamino, monoarylamino, diarylamino, alkoxy, aryloxy, haloalkyl, aralkyl, ester, alkoxycarbonyl, acylamino, alkoxycarbonylamino, aryloxycarbonylamino, sulfonylamino, sulfamoyl, carbamoyl, alkylthio, ureido, phosphoramide, silyl, polymeric; or any conjugate or combination thereof.
 13. The OLED of claim 1, wherein the ratio of first complex to second complex in the organic region is about 1:1.
 14. The OLED of claim 1, wherein the ratio of first complex to second complex in the organic region is about 96:4.
 15. The OLED of claim 1, wherein one of the first complex and the second complex is a red emitter; and the other of the first complex and the second complex is a green emitter.
 16. The OLED of claim 6, wherein M in one of the first complex and the second complex is Pt(II); and M in the other of the first complex and the second complex is Pd(II).
 17. The OLED of claim 6, wherein the first complex and the second complex each have a structure of General Formula I.
 18. The OLED of claim 1, wherein at least one of the first complex and the second complex is selected from the group consisting of:


19. A consumer product comprising an organic light emitting device (OLED) comprising: an anode; a cathode; and an organic region, disposed between the anode and the cathode, comprising a first complex and a second complex; wherein when a voltage is applied across the anode and cathode at room temperature, the OLED emits a luminescent radiation that comprises one or more luminescent radiation components resulting from the formation of at least one exciplex; wherein the exciplex is formed by at least one of the following aggregate types: 1) at least one aggregate within the first complex, and at least one aggregate within the second complex; 2) at least one aggregate between the first and the second complex; and 3) both 1 and
 2. 20. The consumer product of claim 19, wherein the consumer product is selected from the group consisting of a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior illumination and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cell phone, tablet, a phablet, a personal digital assistant (PDA), a wearable device, a laptop computer, a digital camera, a camcorder, a viewfinder, a micro-display that is less than 2 inches diagonal, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall comprising multiple displays tiled together, a theater or stadium screen, and a sign. 